|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
CA2785536C
(en)
|
2009-12-30 |
2018-02-27 |
Arqule, Inc. |
Substituted imidazopyridinyl-aminopyridine compounds
|
|
KR20130059400A
(ko)
|
2010-08-25 |
2013-06-05 |
(주)네오팜 |
신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
|
|
MY170236A
(en)
|
2010-10-06 |
2019-07-11 |
Glaxosmithkline Llc |
Benzimidazole derivatives as pi3 kinase inhibitors
|
|
US9388140B2
(en)
|
2011-03-31 |
2016-07-12 |
Bayer Intellectual Property Gmbh |
Substituted benzimidazoles
|
|
WO2012177852A1
(en)
|
2011-06-24 |
2012-12-27 |
Arqule, Inc |
Substituted imidazopyridinyl compounds
|
|
US8609688B2
(en)
|
2011-06-24 |
2013-12-17 |
Arqule, Inc. |
Substituted imidazopyridinyl-aminopyridine compounds
|
|
WO2013191188A1
(ja)
*
|
2012-06-22 |
2013-12-27 |
住友化学株式会社 |
縮合複素環化合物
|
|
CN102924460B
(zh)
*
|
2012-11-05 |
2015-12-16 |
南京师范大学 |
一种4H-吡咯并[1,2-a]苯并咪唑衍生物及其合成方法和应用
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
CN103130811B
(zh)
*
|
2013-03-11 |
2015-02-25 |
河南师范大学 |
一种5,6-二氢吡唑并[1,5-c]喹唑啉类化合物的合成方法
|
|
CN105189495A
(zh)
*
|
2013-03-15 |
2015-12-23 |
先正达参股股份有限公司 |
新颖的杀微生物剂
|
|
US9682971B2
(en)
|
2013-03-15 |
2017-06-20 |
Janssen Pharmaceutica Nv |
1,2,5-Substituted benzimidazoles as flap modulators
|
|
US8952177B2
(en)
|
2013-03-15 |
2015-02-10 |
Janssen Pharmaceutica Nv |
1,2,6-substituted benzimidazoles as FLAP modulators
|
|
JP6461118B2
(ja)
|
2013-06-21 |
2019-01-30 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規の置換された二環式化合物
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
JP6542212B2
(ja)
|
2013-07-31 |
2019-07-10 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規キナゾリノン
|
|
WO2015077572A1
(en)
|
2013-11-22 |
2015-05-28 |
CL BioSciences LLC |
Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
|
|
CN103965136B
(zh)
*
|
2014-05-07 |
2016-09-07 |
苏州波菲特新材料科技有限公司 |
一种制备n-甲基噻唑啉-2-酮类化合物的方法
|
|
US10179125B2
(en)
|
2014-12-01 |
2019-01-15 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
US10710992B2
(en)
|
2014-12-01 |
2020-07-14 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
WO2016092375A1
(en)
|
2014-12-11 |
2016-06-16 |
Zenith Epigenetics Corp. |
Substituted heterocycles as bromodomain inhibitors
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
CN108473495B
(zh)
|
2015-11-20 |
2022-04-12 |
福马治疗有限公司 |
作为泛素-特异性蛋白酶1抑制剂的嘌呤酮
|
|
CN106519250A
(zh)
*
|
2016-09-29 |
2017-03-22 |
辽宁石油化工大学 |
含氮小分子有机配体调节荧光发射性质的一维链状铜配位聚合物的制备方法
|
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
EP3562306B1
(en)
|
2016-12-29 |
2025-02-26 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
JP7227157B2
(ja)
|
2016-12-29 |
2023-02-21 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
金属酵素阻害剤化合物
|
|
MX388196B
(es)
|
2017-04-26 |
2025-03-19 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
TWI795440B
(zh)
|
2017-09-15 |
2023-03-11 |
美商佛瑪治療公司 |
作為ＣＢＰ／ｐ３００抑制劑之四氫─咪唑並喹啉化合物
|
|
GB201800688D0
(en)
|
2018-01-16 |
2018-02-28 |
Redag Crop Prot Ltd |
Agricultural chemicals
|
|
GB201806320D0
(en)
|
2018-04-18 |
2018-05-30 |
Cellcentric Ltd |
Process
|
|
US10870648B2
(en)
|
2018-06-29 |
2020-12-22 |
Forma Therapeutics, Inc. |
Inhibiting CREB binding protein (CBP)
|
|
MX2021003904A
(es)
|
2018-10-05 |
2021-10-26 |
Annapurna Bio Inc |
Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj.
|
|
JP2022516969A
(ja)
|
2019-01-08 |
2022-03-03 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
金属酵素阻害剤化合物
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020190791A1
(en)
|
2019-03-15 |
2020-09-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (creb)
|
|
CN110982806B
(zh)
*
|
2019-08-30 |
2022-09-02 |
浙江工业大学 |
一种蛋白质芳基衍生物及其制备方法
|
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
|
CN111206260B
(zh)
*
|
2020-02-12 |
2022-03-22 |
齐鲁工业大学 |
一种吡啶并[1,2-a]苯并咪唑类化合物的电化学合成方法
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
SMT202500481T1
(it)
|
2021-06-04 |
2026-01-12 |
Vertex Pharma |
N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
|